Product fact sheet
NOW Prebiotic Bifido Boost Powder: PreticX XOS Evidence & Dose
Evidence-aware fact sheet for NOW Prebiotic Bifido Boost Powder, with 2.2 g PreticX XOS per serving, human XOS dose comparisons, microbiota findings and important efficacy limits.
A unusually clean dose-to-ingredient-evidence match for an XOS prebiotic: the current NOW label supplies 2.2 g xylooligosaccharides from PreticX per teaspoon, within the low-gram range used in human XOS trials that increased fecal Bifidobacterium. The evidence supports a microbiota effect more clearly than symptom relief or metabolic treatment.
Adults comparing a low-gram XOS prebiotic with a clearly disclosed dose, Shoppers who want a prebiotic aimed at bifidogenic effects without a large multi-fiber blend
Anyone expecting proven treatment of IBS, diabetes, insulin resistance or another disease, People who want a product-specific randomized trial of the exact NOW finished powder
Key tradeoff: The 2.2 g XOS dose maps reasonably well to human microbiota trials and is easy to audit, but most of the evidence concerns bacterial composition rather than clinically important symptoms or disease outcomes.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
NOW Prebiotic Bifido Boost is a single-purpose prebiotic powder built around xylooligosaccharides (XOS) from the branded PreticX complex. Its strongest feature is not the brand name—it is the unusually transparent, low-gram XOS dose.
The current NOW manufacturer page lists 2.2 g XOS per level teaspoon, with a serving weight of about 3.4 g. The other listed ingredient is maltodextrin.
Why the 2.2 g dose is interesting
A double-blind randomized placebo-controlled study in healthy adults compared 1.4 g/day XOS, 2.8 g/day XOS and placebo for eight weeks. Both XOS groups increased fecal Bifidobacterium, with the 2.8 g/day dose producing the larger increase. The intervention was generally well tolerated in that study.
NOW’s current 2.2 g/day serving sits directly between those two studied doses. That is a much stronger dose-to-literature bridge than products that list a prebiotic ingredient but provide only a few hundred milligrams.
It is still ingredient-level evidence, not a randomized trial of this exact NOW powder.
What the evidence does—and does not—show
The best-supported low-dose XOS endpoint is bifidogenic activity: increasing Bifidobacterium in the stool of healthy adults.
That is not the same as proving symptom relief or disease treatment. In a small randomized pilot using 2 g/day XOS in healthy and prediabetic adults, XOS changed parts of the gut microbiota but did not significantly improve body composition, HOMA-IR, serum glucose or triglycerides. More recent human work in insulin-resistant adults likewise has not established improved insulin sensitivity from XOS supplementation.
For Homeapotherapy, the fair summary is therefore:
- good evidence that XOS can alter selected gut bacteria at low gram doses;
- reasonable dose proximity between the current NOW serving and human XOS trials;
- much weaker evidence for clinically meaningful symptom or metabolic outcomes.
Current label details
| Feature | Current specification |
|---|---|
| Prebiotic | Xylooligosaccharides (XOS) from PreticX |
| XOS per serving | 2.2 g (2,200 mg) |
| Serving size | 1 level teaspoon, approximately 3.4 g |
| Other ingredient | Maltodextrin |
| Current suggested use | One teaspoon daily mixed into water, another beverage or food |
| Label age range | Adults and children age 4+ |
| Storage | Cool, dry place after opening |
The manufacturer also lists Non-GMO Project Verified, vegan/vegetarian and several allergen-free positioning claims. Those are product-quality or dietary-suitability attributes; they are not evidence that XOS treats a gastrointestinal disease.
A formulation-version warning
Some older retailer listings show a lower XOS amount than NOW’s current official product page. Homeapotherapy uses the current manufacturer label: 2.2 g XOS per teaspoon. If you are buying older inventory or comparing marketplace listings, check the Supplement Facts panel on the actual bottle.
Who may find this product interesting
This is a rational comparator for someone who specifically wants to trial XOS and values a dose that can be mapped to human research without complicated arithmetic.
It is less compelling if your real goal is relief of a defined condition such as IBS-C, chronic constipation, diabetes or inflammatory bowel disease. In those situations, the strongest intervention may be a different fiber—or medical evaluation and condition-specific treatment rather than a microbiome supplement.
Tolerability and safety
The low-dose randomized XOS study reported good gastrointestinal tolerance overall, but individual responses to fermentable carbohydrates still vary. Starting with one new prebiotic at a time makes it easier to identify whether it helps or worsens gas, distension, cramping or stool changes.
The current NOW label advises medical consultation during pregnancy or nursing, when taking medication, or when a medical condition is present. The fact that the label includes children age 4+ should not be mistaken for strong pediatric efficacy evidence for the outcomes discussed above.
Read Prebiotics: Best Fiber Types, Doses & Products by Evidence to compare XOS with PHGG, B-GOS, inulin and psyllium.
Formula facts
Ingredients, actives and label details
- Prebiotic substrate
- Xylooligosaccharides (XOS) from PreticX prebiotic complex Basis: Manufacturer Source: NOW Prebiotic Bifido Boost Powder — official product information
- XOS per serving
- 2.2 g (2,200 mg) per level teaspoon; serving weighs about 3.4 g Basis: Manufacturer Source: NOW Prebiotic Bifido Boost Powder — official product information
- Other ingredient
- Maltodextrin Basis: Manufacturer Source: NOW Prebiotic Bifido Boost Powder — official product information
- Dose-to-trial fit
- Human randomized evidence found increased Bifidobacterium at 1.4 and 2.8 g XOS/day; the current retail serving of 2.2 g falls between those studied doses Basis: Randomized trial Source: Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
- Best-supported endpoint
- Increase in fecal Bifidobacterium in healthy adults; 2.8 g/day produced a larger increase than 1.4 g/day Basis: Randomized trial Source: Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
- Metabolic evidence limit
- A 2 g/day pilot altered some gut taxa in healthy and prediabetic adults but did not significantly improve body composition, HOMA-IR, serum glucose or triglycerides; newer insulin-resistance research likewise did not establish improved insulin sensitivity Basis: Clinical study Source: Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study
- Current label usage
- Adults and children age 4+ are directed to take one level teaspoon daily mixed into water, another beverage or food Basis: Manufacturer Label eligibility is not the same as pediatric efficacy evidence. Source: NOW Prebiotic Bifido Boost Powder — official product information
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- NOW Prebiotic Bifido Boost Powder — official product informationNOW Foods · Manufacturer · retrieved 2026-08-12
- Prebiotic Bifido Boost Powder — Dietary Supplement Label DatabaseNIH Office of Dietary Supplements · Government health · retrieved 2026-08-12
- Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiotaFood & Function · Professional health · retrieved 2026-08-12
- Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot studyFrontiers in Physiology · Professional health · retrieved 2026-08-12
- Prebiotic xylo-oligosaccharides cause modest taxonomic shifts in the gut microbiota but do not increase insulin sensitivity in insulin resistant individualsNutrition & Metabolism · Professional health · retrieved 2026-08-12